Nomad & Broker Appointment

RNS Number : 7274Z
Futura Medical PLC
28 September 2009
 




For immediate release 

28 September 2009





Futura Medical plc

('Futura' or 'the Group' or 'the Company')


   Appointment of Nominated Adviser and Broker



Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce the appointment of Nomura Code Securities Limited as the Company's nominated adviser and broker with immediate effect. 





For any further information please contact:


Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0) 1483 685 670



mail to: james.barder@futuramedical.co.uk

www.futuramedical.co.uk 



Nomura Code Securities Limited 


Charles Walker / Giles Balleny

Tel:+44 (0)20 7776 1200



For media enquiries please contact: 




Buchanan Communications


Mark Court / Stasa Filiplic / Jennie Spivey

Tel: +44 (0) 20 7466 5000



 



Notes to Editors

Futura Medical plc


Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.


Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.


www.futuramedical.co.uk



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPILFFTALIDFIA
UK 100

Latest directors dealings